Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 6—June 2008


Inquilinus limosus and Cystic Fibrosis

Fadi Bittar*, Anne Leydier†, Emmanuelle Bosdure†, Alexandre Toro*, Martine Reynaud-Gaubert‡, Stéphanie Boniface‡, Nathalie Stremler†, Jean-Christophe Dubus†, Jacques Sarles†, Didier Raoult*, and Jean-Marc Rolain*Comments to Author 
Author affiliations: *Université de la Méditerranée, Marseille, France; †Hôpital Timone, Marseille, France; ‡Hôpital Sainte Marguerite, Marseille, France;

Main Article


Clinical and epidemiologic features of cystic fibrosis (CF) patients with Inquilinus limosus*

Case no. Age, y/sex Lung transplant Positive samples Clinical manifestation (first isolation) Growth on MacConkey agar Growth on selective agar (d) Phenotypic identification† Other associated pathogens Reference
1 22/F Yes Lung explant, BAL, sputum Pneumonia Poor ND AR PA, PM (1)
2 17/M No Sputum Stable No Yes (6 d) SP SA, PA, CA (3)
3 14/F No Sputum Stable No Yes (5 d) SP PA, AF, CA (3)
4 12/M No Sputum Stable ND Yes (ND) SP PA, SM, SA, AX (5)
5 13/F No Sputum Exacerbation ND Yes (ND) SP PA, SA, AF (5)
6 8/M No Sputum Stable ND Yes (ND) SP PA (5)
7 10/M No Sputum Stable ND Yes (ND) SP None (5)
8 18/M No Sputum Exacerbation ND Yes (ND) AR PA, SA, AF (5)
9 16/F No Sputum Severe exacerbation ND ND PA PA (4)
10 19/M No Sputum Stable ND ND ND PA (4)
11 17/F No Sputum Exacerbation ND ND ND PA, CA, AF (4)
12 20/F No Sputum Exacerbation ND ND ND PA, SA, CA, AF (4)
13 17/F No Sputum Stable ND ND ND PA, SA, SM, CA, AF (4)
14 35/M No Sputum Respiratory decline ND ND PA PA, SM, SMA (4)
15 17/F No Sputum Stable No Yes (4 d) SP CA This study
16 2/M No Sputum Productive cough No Yes (3 d) SP SA, HI This study
17 21/M No Sputum Exacerbation No Yes (3 d) AR PA, AF This study
18 15/M No Sputum Fever and thoracic pain No Yes (3 d) AR SA This study

*BAL, bronchoalveolar lavage; ND, not determined; AR, Agrobacterium radiobacter; PA, Pseudomonas aeruginosa; PM, Proteus mirabilis; SP, Sphingomonas paucimobilis; SA, Staphylococcus aureus; CA, Candida albicans; AF, Aspergillus fumigatus; SM, Stenotrophomonas maltophilia; AX, Achromobacter xylosoxidans; SMA, Serratia marcescens; HI, Haemophilus influenzae.
†Phenotypic identification was obtained by using the BIOLOG GN MicroPlate assay (BIOLOG Inc., Hayward, CA, USA) for case 1 and the API 20NE kit system (bioMérieux, Marcy l’Etoile, France) for cases 2–8 and 15–18.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO